The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2017
Filed:
Mar. 15, 2013
Applicant:
Immix Corporation, Los Angeles, CA (US);
Inventors:
Sean Senn, West Hills, CA (US);
Ilya Rachman, Los Angeles, CA (US);
Assignee:
Immix Biopharma, Inc., Los Angeles, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 9/107 (2006.01); A61K 31/12 (2006.01); A61K 31/713 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/1075 (2013.01); A61K 31/12 (2013.01); A61K 31/713 (2013.01); A61K 47/6907 (2017.08); C07K 16/28 (2013.01); A61K 9/107 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); Y10T 428/2982 (2015.01);
Abstract
The invention relates to the treatment of cancer. In one embodiment, the present invention provides a composition comprising a micelle construct attached to a glut-1 antibody and a curcumin molecule. In another embodiment, the present invention provides a method of treating colon and/or breast cancer by administering a therapeutically effective amount of composition comprising a targeted construct attached to an inhibitor of NF-kB.